Vivani Medical Management
Management criteria checks 1/4
Vivani Medical's CEO is Adam Mendelsohn, appointed in Aug 2022, has a tenure of 2.25 years. total yearly compensation is $1.04M, comprised of 57.2% salary and 42.8% bonuses, including company stock and options. directly owns 6.69% of the company’s shares, worth €4.52M. The average tenure of the management team and the board of directors is 2.3 years and 2.8 years respectively.
Key information
Adam Mendelsohn
Chief executive officer
US$1.0m
Total compensation
| CEO salary percentage | 57.2% |
| CEO tenure | 2.3yrs |
| CEO ownership | 6.7% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$23m |
| Jun 30 2024 | n/a | n/a | -US$24m |
| Mar 31 2024 | n/a | n/a | -US$25m |
| Dec 31 2023 | US$1m | US$598k | -US$26m |
| Sep 30 2023 | n/a | n/a | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$19m |
| Mar 31 2023 | n/a | n/a | -US$16m |
| Dec 31 2022 | US$312k | US$300k | -US$14m |
| Sep 30 2022 | n/a | n/a | -US$10m |
| Jun 30 2022 | n/a | n/a | -US$15m |
| Mar 31 2022 | n/a | n/a | -US$14m |
| Dec 31 2021 | US$308k | US$300k | -US$13m |
| Dec 31 2020 | US$223k | US$195k | -US$9m |
Compensation vs Market: Adam's total compensation ($USD1.04M) is above average for companies of similar size in the German market ($USD479.80K).
Compensation vs Earnings: Adam's compensation has increased whilst the company is unprofitable.
CEO
Adam Mendelsohn (42 yo)
2.3yrs
Tenure
US$1,044,621
Compensation
Dr. Adam Mendelsohn, Ph.D. serves as Chief Executive Officer and Director at Vivani Medical, Inc. since August 2022 and is its Co-Founder. Dr. Mendelsohn is Chairman of the Board at Cortigent, Inc. and its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 2.3yrs | US$1.04m | 6.69% € 4.5m | |
| Chief Operations Officer | 2.2yrs | US$725.50k | 0% € 0 | |
| Chief Medical Officer | 2.8yrs | US$661.53k | 0% € 0 | |
| Chief Business Officer & Corporate Secretary | no data | US$245.21k | 0.090% € 61.2k |
2.3yrs
Average Tenure
62.5yo
Average Age
Experienced Management: U5P's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 2.3yrs | US$1.04m | 6.69% € 4.5m | |
| Director | less than a year | no data | 0% € 0 | |
| Advisor | no data | no data | no data | |
| Director | 2.8yrs | US$70.00k | 0% € 0 | |
| Independent Chairman of the Board | 2.8yrs | US$114.00k | 31.06% € 21.0m | |
| Advisor | no data | no data | no data | |
| Independent Director | 2.8yrs | US$106.00k | no data | |
| Independent Director | 2.8yrs | US$90.00k | 0.0039% € 2.7k | |
| Advisor | no data | no data | no data |
2.8yrs
Average Tenure
65yo
Average Age
Experienced Board: U5P's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.